GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Cash on Hand 2019–2025
GeneDx Holdings Corp. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- GeneDx Holdings Corp. cash on hand for the quarter ending December 31, 2025 were 105.0M, a 23.22% increase year-over-year.
- GeneDx Holdings Corp. cash on hand for 2025 were 105.0M, a 23.22% increase from 2024.
- GeneDx Holdings Corp. cash on hand for 2024 were 85.2M, a 14.52% decrease from 2023.
- GeneDx Holdings Corp. cash on hand for 2023 were 99.7M, a 19.57% decrease from 2022.
- GeneDx Holdings Corp. cash on hand for 2022 were 123.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GeneDx Holdings Corp. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $105 |
| 2024 | $85 |
| 2023 | $100 |
| 2022 | $124 |
| 2021 | $401 |
| 2020 | $108 |
| GeneDx Holdings Corp. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $105 |
| 2024-12-31 | $85 |
| 2023-12-31 | $100 |
| 2022-12-31 | $124 |
| 2021-12-31 | $401 |
| 2020-12-31 | $108 |
GeneDx Holdings Corp. Cash on Hand — FAQ
GeneDx Holdings Corp. (WGS) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's cash on hand history?
The chart and table above show GeneDx Holdings Corp.'s cash on hand by year and by quarter, including the growth rate.